Canada Life’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,161
| Closed | -$34K | – | 2422 |
|
|
2022
Q2 | $34K | Sell |
2,161
-1,181
| -35% | -$18K | ﹤0.01% | 2146 |
|
|
2022
Q1 | $54K | Hold |
3,342
| – | – | ﹤0.01% | 2138 |
|
|
2021
Q4 | $51K | Hold |
3,342
| – | – | ﹤0.01% | 2168 |
|
|
2021
Q3 | $29K | Hold |
3,342
| – | – | ﹤0.01% | 2369 |
|
|
2021
Q2 | $34K | Hold |
3,342
| – | – | ﹤0.01% | 2374 |
|
|
2021
Q1 | $40K | Hold |
3,342
| – | – | ﹤0.01% | 2364 |
|
|
2020
Q4 | $30K | Hold |
3,342
| – | – | ﹤0.01% | 2461 |
|
|
2020
Q3 | $20K | Hold |
3,342
| – | – | ﹤0.01% | 2448 |
|
|
2020
Q2 | $29K | Buy |
+3,342
| New | +$28.8K | ﹤0.01% | 2412 |
|
|
2017
Q4 | – | Sell |
-3,200
| Closed | -$19K | – | 2573 |
|
|
2017
Q3 | $19K | Hold |
3,200
| – | – | ﹤0.01% | 2496 |
|
|
2017
Q2 | $25K | Hold |
3,200
| – | – | ﹤0.01% | 2471 |
|
|
2017
Q1 | $29K | Hold |
3,200
| – | – | ﹤0.01% | 2417 |
|
|
2016
Q4 | $35K | Hold |
3,200
| – | – | ﹤0.01% | 2404 |
|
|
2016
Q3 | $52K | Hold |
3,200
| – | – | ﹤0.01% | 2331 |
|
|
2016
Q2 | $30K | Buy |
+3,200
| New | +$34.8K | ﹤0.01% | 2426 |
|
Other funds holding NPTN
Canada Life's NPTN Position: Q3 2022 in Review
Canada Life sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 2,161 shares — an estimated $34K sold.
Canada Life first reported a position in NPTN in Q2 2016 and held it in 15 quarters. The position peaked at $54K in Q1 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.
- Canada Life reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
- Canada Life sold 2,161 NEOPHOTONICS CORP shares in Q3 2022, an estimated $34K.
- Canada Life first reported a position in NEOPHOTONICS CORP in Q2 2016 and held it in 15 quarters.
- Canada Life's NEOPHOTONICS CORP position peaked at $54K in Q1 2022.
- 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.
Based on Canada Life's 13F filing for Q3 2022, filed 1 Nov 2022.